We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
203.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.35%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$216M
AUM Growth
+$17.6M
(+8.9%)
Cap. Flow
-$4.87M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
44.96%
Holding
70
New
3
Increased
13
Reduced
28
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MODN
MODEL N, INC.
MODN
|
+$4.66M |
| 2 |
AKRX
Akorn Inc
AKRX
|
+$4.64M |
| 3 |
Option Care Health
OPCH
|
+$4.57M |
| 4 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$3.98M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$2.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$8.53M |
| 2 |
AngioDynamics
ANGO
|
+$3.36M |
| 3 |
ELGX
Endologix Inc
ELGX
|
+$3.12M |
| 4 |
Arrowhead Research
ARWR
|
+$2.37M |
| 5 |
Insmed
INSM
|
+$2.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.91% |
| 2 | Energy | 4.55% |
| 3 | Miscellaneous | 3.27% |
| 4 | Communication Services | 2.46% |
| 5 | Real Estate | 1.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$2.42B
| $16.4M | 7.59% |
2,038,988
-1,064,398
| -34% | -$8.53M |
|
|
AKRX
2
DELISTED
Akorn Inc
AKRX
| $15M | 6.94% |
525,737
+167,212
| +47% | +$4.64M |
|
3
AtriCure
ATRC
$2.87B
| $13M | 6.04% |
922,590
-4,620
| -0.5% | -$70.4K |
|
|
LHCG
4
DELISTED
LHC Group LLC
LHCG
| $9.82M | 4.55% |
226,943
+54,406
| +32% | +$2.22M |
|
|
ENZ
5
DELISTED
Enzo Biochem, Inc.
ENZ
| $8.15M | 3.78% |
1,364,963
-366,823
| -21% | -$2.04M |
|
6
Harvard Bioscience
HBIO
$36.4M
| $7.84M | 3.63% |
274,020
+59,001
| +27% | +$1.88M |
|
|
ENTL
7
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $7.24M | 3.35% |
396,291
-850
| -0.2% | -$14.6K |
|
|
TLGT
8
DELISTED
Teligent, Inc
TLGT
| $7.19M | 3.33% |
100,753
-1,153
| -1% | -$67.1K |
|
|
OXFD
9
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $6.31M | 2.92% |
700,849
+154,125
| +28% | +$1.51M |
|
|
AMED
10
DELISTED
Amedisys
AMED
| $6.1M | 2.82% |
120,778
-26,040
| -18% | -$1.31M |
|
|
NXTM
11
DELISTED
NxStage Medical Inc.
NXTM
| $5.51M | 2.55% |
254,113
-3,814
| -1% | -$68K |
|
12
LeMaitre Vascular
LMAT
$1.83B
| $5.5M | 2.55% |
385,562
-6,755
| -2% | -$103K |
|
13
Orthofix Medical
OFIX
$369M
| $5.5M | 2.55% |
129,745
+44,592
| +52% | +$1.94M |
|
14
HealthStream
HSTM
$866M
| $5.45M | 2.52% |
205,298
+88,730
| +76% | +$2.08M |
|
|
15
Option Care Health
OPCH
$3.53B
| $5.33M | 2.47% |
523,021
+447,493
| +592% | +$4.57M |
|
|
MODN
16
DELISTED
MODEL N, INC.
MODN
| $5.3M | 2.46% |
+397,152
| New | +$4.66M |
|
17
Ligand Pharmaceuticals
LGND
$5.48B
| $5.02M | 2.33% |
67,518
-23,390
| -26% | -$1.74M |
|
|
EVHC
18
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $4.87M | 2.26% |
64,110
-12,896
| -17% | -$916K |
|
|
KTWO
19
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.38M | 2.03% |
+281,975
| New | +$3.98M |
|
|
PETX
20
DELISTED
Aratana Therapeutics, Inc.
PETX
| $4.33M | 2.01% |
684,921
+236,915
| +53% | +$1.52M |
|
|
MDCO
21
DELISTED
Medicines Co
MDCO
| $4.23M | 1.96% |
125,889
+1,149
| +0.9% | +$40.5K |
|
|
BEAT
22
DELISTED
BioTelemetry, Inc.
BEAT
| $4.16M | 1.93% |
255,163
-109,815
| -30% | -$1.62M |
|
|
LDRH
23
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $3.91M | 1.81% |
105,780
-74,136
| -41% | -$2.1M |
|
|
SPNC
24
DELISTED
Spectranetics Corp
SPNC
| $3.71M | 1.72% |
198,219
-85,001
| -30% | -$1.5M |
|
|
SRGA
25
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $3.54M | 1.64% |
32,908
-561
| -2% | -$65.7K |
|
Similar funds
AAM
NPA
SOS
BCM
BFO
AAG
MCIL
TIM
First Light Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, First Light Asset Management held 70 positions worth $216M, up 8.9% from $198M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
First Light Asset Management's Q2 2016 filing shows 3 new, 13 increased, 28 reduced and 5 closed positions. Its largest new stake was MODEL N, INC.: 397,152 shares worth $5.3M. The largest sale was NeoGenomics, an estimated $8.53M.
By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 92% a quarter earlier, followed by Energy and Miscellaneous.
- First Light Asset Management's largest Q2 2016 buy was MODEL N, INC.: 397,152 shares worth $5.3M.
- First Light Asset Management added most to Akorn Inc in Q2 2016, an estimated $4.64M increase.
- First Light Asset Management's biggest Q2 2016 reduction was NeoGenomics, cutting an estimated $8.53M.
- First Light Asset Management fully exited AngioDynamics in Q2 2016, selling an estimated $3.36M.
- First Light Asset Management's ten largest holdings make up 45% of its $216M portfolio in Q2 2016.
- First Light Asset Management opened 3 new positions and closed 5 in Q2 2016.
- First Light Asset Management's portfolio value rose 8.9% quarter-over-quarter to $216M.
Based on First Light Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.